Neoplasms, Colorectal Completed Phase 2 Trials for Regorafenib (DB08896)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02195011Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver MetastasesTreatment
NCT02465502Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal CancerTreatment
NCT01875380Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal CancerTreatment
NCT01289821First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With RegorafenibTreatment